| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 as of 6/30 |
| Market
Cap: |
13.10(B) |
| Last
Volume: |
23,811,358 |
Avg
Vol: |
17,270,067 |
| 52
Week Range: |
$4.97 - $9.25 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 8.3 |
| Insider 6 Months : 8.3 |
| Insider 3/6 Months : 17.1 |
|
| Guru Rank Number : 453 |
| Guru Rank Value : 0.9 |
| Guru Occurances : 1 |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
Company Profile Boston Scientific is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. As of Dec 31 2011, Co.'s products were provided for sale by seven core businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology/Women's Health, Neuromodulation, and Electrophysiology. Also, at such date, Co. had four reportable segments based on geographic regions: the U.S.; EMEA, consisting of Europe, the Middle East and Africa; Japan; and Inter-Continental, consisting of Co.'s Asia Pacific and the Americas operating segments, which include the markets of Brazil, China and India. .
|
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
30,000 |
30,000 |
139,000 |
447,100 |
| Total Buy Value |
$232,800 |
$232,800 |
$803,204 |
$2,642,264 |
| Total People Bought |
1 |
1 |
4 |
5 |
| Total Buy Transactions |
1 |
1 |
6 |
16 |
| Total Shares Sold |
0 |
0 |
10,914,975 |
17,104,495 |
| Total Sell Value |
$0 |
$0 |
$0 |
$118,452 |
| Total People Sold |
0 |
0 |
2 |
5 |
| Total Sell Transactions |
0 |
0 |
39 |
69 |
| End Date |
2013-02-21 |
2012-11-20 |
2012-05-22 |
2011-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Capello Jeffrey D |
EVP & Chief Financial Officer |
• • – |
2013-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,235 |
191,448 |
|
- |
|
| Capello Jeffrey D |
EVP & Chief Financial Officer |
• • – |
2013-05-12 |
4 |
D |
$8.45 |
$19,934 |
D/D |
(2,359) |
189,089 |
|
- |
|
| Bartlett Katharine T |
Director |
• • – |
2013-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
22,756 |
52,464 |
|
- |
|
| Nicholas Peter M |
Director |
• • – |
2013-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
22,756 |
3,437,495 |
|
- |
|
| Reinhardt Uwe E |
Director |
• • – |
2013-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
22,756 |
146,202 |
|
- |
|
| Byrnes Bruce L |
Director |
• • – |
2013-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
22,756 |
98,920 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2013-05-06 |
4 |
B |
$7.76 |
$232,800 |
D/D |
30,000 |
509,304 |
2.39 |
18% |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2013-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,746 |
143,951 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2013-05-01 |
4 |
D |
$7.49 |
$36,012 |
D/D |
(4,808) |
139,143 |
|
- |
|
| Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,190 |
75,306 |
|
- |
|
| Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$10,405 |
D/D |
(1,408) |
73,898 |
|
- |
|
| Onuscheck John Michael |
SVP & President, EMEA |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,237 |
74,226 |
|
- |
|
| Onuscheck John Michael |
SVP & President, EMEA |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$17,706 |
D/D |
(2,396) |
71,830 |
|
- |
|
| Pierce David A |
SVP and President, Endoscopy |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,491 |
26,582 |
|
- |
|
| Pierce David A |
SVP and President, Endoscopy |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$8,417 |
D/D |
(1,139) |
25,443 |
|
- |
|
| Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,190 |
88,382 |
|
- |
|
| Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$10,405 |
D/D |
(1,408) |
86,974 |
|
- |
|
| Pucel Kenneth |
EVP, Glob Ops, Qual & Tech |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,474 |
136,154 |
|
- |
|
| Pucel Kenneth |
EVP, Glob Ops, Qual & Tech |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$26,013 |
D/D |
(3,520) |
132,634 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,379 |
84,544 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$20,189 |
D/D |
(2,732) |
81,812 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,474 |
132,620 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$25,237 |
D/D |
(3,415) |
129,205 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,269 |
77,121 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$6,156 |
D/D |
(833) |
76,288 |
|
- |
|
1783 Records found
|
|
Page 1 of 72 |
|
|
0.03 (0.33%) 
